Regorafenib: lights and shadows of antiangiogenic therapies in gastric cancer

di Vivaldi, Caterina, Falcone, Alfredo, Fornaro, Lorenzo
Pubblicato in Transl Gastroenterol Hepatol (2017)

Apatinib in Advanced Gastric Cancer: A Doubtful Step Forward

di Fornaro, Lorenzo, Vasile, Enrico, Falcone, Alfredo
Pubblicato in J Clin Oncol (2016)

Bevacizumab as maintenance therapy in mCRC: Interpreting results of the MOMA trial

di Marmorino, Federica, Falcone, Alfredo, Cremolini, Chiara
Pubblicato in Oncotarget (2019)

The Winding Roadmap of Biomarkers Toward Clinic: Lessons from Predictors of Resistance to Anti-EGFRs in Metastatic Colorectal Cancer

di Antoniotti, Carlotta, Ongaro, Elena, Falcone, Alfredo, Cremolini, Chiara
Pubblicato in Int J Mol Sci (2018)

BRAF mutant metastatic colorectal cancers: new arrows in our quiver

di Cremolini, Chiara, Moretto, Roberto, Zucchelli, Gemma, Falcone, Alfredo
Pubblicato in Ann Transl Med (2019)

Comment on: ‘Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort'

di Vivaldi, Caterina, Fornaro, Lorenzo, Caparello, Chiara, Falcone, Alfredo, Vasile, Enrico
Pubblicato in Br J Cancer (2016)

Immune Checkpoint Inhibitors in pMMR Metastatic Colorectal Cancer: A Tough Challenge

di Marmorino, Federica, Boccaccino, Alessandra, Germani, Marco Maria, Falcone, Alfredo, Cremolini, Chiara
Pubblicato in Cancers (Basel) (2020)

Beyond KRAS: perspectives on new potential markers of intrinsic and acquired resistance to epidermal growth factor receptor inhibitors in metastatic colorectal cancer

di Loupakis, Fotios, Cremolini, Chiara, Fontanini, Gabriella, Stasi, Irene, Salvatore, Lisa, Falcone, Alfredo
Pubblicazione 2009

FLOaTing toward new standards in locally advanced resectable gastroesophageal cancer

di Fornaro, Lorenzo, Vivaldi, Caterina, Calvetti, Lorenzo, Cappetta, Alessandro, Falcone, Alfredo, Aprile, Giuseppe
Pubblicato in J Thorac Dis (2019)

KRAS Early Testing: Consensus Initiative and Cost-Effectiveness Evaluation for Metastatic Colorectal Patients in an Italian Setting

di Barone, Carlo, Pinto, Carmine, Normanno, Nicola, Capussotti, Lorenzo, Cognetti, Francesco, Falcone, Alfredo, Mantovani, Lorenzo
Pubblicazione 2014

Bevacizumab in the pre-operative treatment of locally advanced rectal cancer: A systematic review

di Fornaro, Lorenzo, Caparello, Chiara, Vivaldi, Caterina, Rotella, Virginia, Musettini, Gianna, Falcone, Alfredo, Baldini, Editta, Masi, Gianluca
Pubblicazione 2014

Metastatic BRAF K601E-mutated melanoma reaches complete response to MEK inhibitor trametinib administered for over 36 months

di Marconcini, Riccardo, Galli, Luca, Antonuzzo, Andrea, Bursi, Simona, Roncella, Claudia, Fontanini, Gabriella, Sensi, Elisa, Falcone, Alfredo
Pubblicato in Exp Hematol Oncol (2017)

Prognostic relevance of a T-type calcium channels gene signature in solid tumours: A correlation ready for clinical validation

di Fornaro, Lorenzo, Vivaldi, Caterina, Lin, Dong, Xue, Hui, Falcone, Alfredo, Wang, Yuzhuo, Crea, Francesco, Bootman, Martin D.
Pubblicato in PLoS One (2017)

Dihydropyrimidine dehydrogenase polymorphisms and fluoropyrimidine toxicity: ready for routine clinical application within personalized medicine?

di Del Re, Marzia, Di Paolo, Antonello, van Schaik, Ron H., Bocci, Guido, Simi, Paolo, Falcone, Alfredo, Danesi, Romano
Pubblicazione 2010

Optimization of biomarkers-based classification scores as progression-free survival predictors: an intuitive graphical representation

di Manciu, Marian, Hosseini, Sorour, Di Desidero, Teresa, Allegrini, Giacomo, Falcone, Alfredo, Bocci, Guido, Kirken, Robert A, Francia, Giulio
Pubblicato in Future Sci OA (2018)

Beyond the Guidelines: The Grey Zones of the Management of Gastric Cancer. Consensus Statements from the Gastric Cancer Italian Network (GAIN)

di Fornaro, Lorenzo, Spallanzani, Andrea, de Vita, Ferdinando, D’Ugo, Domenico, Falcone, Alfredo, Lorenzon, Laura, Tirino, Giuseppe, Cascinu, Stefano
Pubblicato in Cancers (Basel) (2021)

Immune Checkpoint Inhibitors in Esophageal Cancers: Are We Finally Finding the Right Path in the Mist?

di Vivaldi, Caterina, Catanese, Silvia, Massa, Valentina, Pecora, Irene, Salani, Francesca, Santi, Stefano, Lencioni, Monica, Vasile, Enrico, Falcone, Alfredo, Fornaro, Lorenzo
Pubblicato in Int J Mol Sci (2020)

Real-world treatment patterns, healthcare resource use and clinical outcomes of patients receiving second line therapy for advanced or metastatic gastric cancer

di Gómez-Ulloa, David, Amonkar, Mayur, Kothari, Smita, Cheung, Winson Y., Chau, Ian, Zalcberg, John R., Lara Suriñach, Núria, Falcone, Alfredo
Pubblicato in BMC Gastroenterol (2020)

Tumor Regression Grading Assessment in Locally Advanced Pancreatic Cancer After Neoadjuvant FOLFIRINOX: Interobserver Agreement and Prognostic Implications

di Cacciato Insilla, Andrea, Vivaldi, Caterina, Giordano, Mirella, Vasile, Enrico, Cappelli, Carla, Kauffmann, Emanuele, Napoli, Niccolò, Falcone, Alfredo, Boggi, Ugo, Campani, Daniela
Pubblicato in Front Oncol (2020)

Clinical and economic effect of administration of red blood product transfusions in an outpatient supportive care cancer service

di Sbrana, Andrea, Paolieri, Federico, Bloise, Francesco, Danova, Marco, Galli, Luca, Brunetti, Isa M., Vasile, Enrico, Ricci, Sergio, Falcone, Alfredo, Antonuzzo, Andrea
Pubblicato in Biomed Rep (2020)